erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Osteitis D010000 10 associated lipids
Orthomyxoviridae Infections D009976 3 associated lipids
Psittacosis D009956 4 associated lipids
Ophthalmia Neonatorum D009878 1 associated lipids
Endophthalmitis D009877 12 associated lipids
Obesity D009765 29 associated lipids
Nocardia Infections D009617 6 associated lipids
Neutropenia D009503 15 associated lipids
Hereditary Sensory and Autonomic Neuropathies D009477 1 associated lipids
Nervous System Diseases D009422 37 associated lipids
Nephritis, Interstitial D009395 10 associated lipids
Nausea D009325 7 associated lipids
Nasopharyngitis D009304 2 associated lipids
Nasopharyngeal Diseases D009302 2 associated lipids
Nasal Polyps D009298 26 associated lipids
Myiasis D009198 1 associated lipids
Mycoplasmatales Infections D009180 6 associated lipids
Mycoplasma Infections D009175 13 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Myasthenia Gravis D009157 5 associated lipids
Multiple Myeloma D009101 13 associated lipids
Stomatognathic Diseases D009057 1 associated lipids
Microphthalmos D008850 1 associated lipids
Meningitis, Listeria D008584 1 associated lipids
Meningitis, Haemophilus D008583 3 associated lipids
Megacolon D008531 1 associated lipids
Maxillofacial Injuries D008446 1 associated lipids
Mastoiditis D008417 2 associated lipids
Marfan Syndrome D008382 2 associated lipids
Mycetoma D008271 4 associated lipids
Lymphogranuloma Venereum D008219 4 associated lipids
Lymphangitis D008205 4 associated lipids
Lymphadenitis D008199 8 associated lipids
Lyme Disease D008193 5 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lupus Erythematosus, Cutaneous D008178 2 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lung Diseases, Obstructive D008173 10 associated lipids
Lung Diseases D008171 37 associated lipids
Long QT Syndrome D008133 10 associated lipids
Liver Diseases D008107 31 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Liver Cirrhosis, Alcoholic D008104 17 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Liver Abscess D008100 6 associated lipids
Listeriosis D008088 12 associated lipids
Lipidoses D008064 7 associated lipids
Leukemia, Lymphoid D007945 18 associated lipids
Leukemia P388 D007941 43 associated lipids
Leukemia D007938 74 associated lipids
Leprosy D007918 8 associated lipids
Leishmaniasis D007896 19 associated lipids
Legionnaires' Disease D007877 4 associated lipids
Legionellosis D007876 3 associated lipids
Laryngitis D007827 5 associated lipids
Lacrimal Duct Obstruction D007767 1 associated lipids
Labyrinth Diseases D007759 3 associated lipids
Obstetric Labor, Premature D007752 9 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Keratoderma, Palmoplantar D007645 1 associated lipids
Keratoconjunctivitis D007637 3 associated lipids
Jejunal Diseases D007579 3 associated lipids
Jaw Abnormalities D007569 1 associated lipids
Ischemia D007511 18 associated lipids
Intraoperative Complications D007431 5 associated lipids
Intestinal Pseudo-Obstruction D007418 5 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Intestinal Atresia D007409 3 associated lipids
Inflammation D007249 119 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Inappropriate ADH Syndrome D007177 4 associated lipids
Impetigo D007169 3 associated lipids
Hypoventilation D007040 2 associated lipids
Hypothermia D007035 19 associated lipids
Hypotension D007022 41 associated lipids
Hypertension D006973 115 associated lipids
Hypersplenism D006971 3 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hypersensitivity D006967 22 associated lipids
Hyperhidrosis D006945 2 associated lipids
Hyperemesis Gravidarum D006939 2 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Hoarseness D006685 2 associated lipids
HIV Seropositivity D006679 15 associated lipids
Herpes Zoster Ophthalmicus D006563 2 associated lipids
Herpes Genitalis D006558 2 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hepatitis, Viral, Human D006525 3 associated lipids
Hemolysis D006461 131 associated lipids
Hemoglobin SC Disease D006450 2 associated lipids
Hematuria D006417 13 associated lipids
Hematemesis D006396 1 associated lipids
Heart Murmurs D006337 1 associated lipids
Heart Failure D006333 36 associated lipids
Cardiomegaly D006332 31 associated lipids
Heart Diseases D006331 8 associated lipids
Heart Block D006327 3 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Hearing Loss, Functional D006315 2 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Chałasińska B and Zakrewski Z [Release of erythromycin from enteric-coated tablets]. 1985 Acta Pol Pharm pmid:4013800
Chojnowski W [Binding of beta-hydroxyethylpiperazinmethyltetracycline phenoxypenicillinate, phenoxymethylpenicillin (PV), cloxacillin (CL), erythromycin lactobionate (LE), lincomycin (LK) and tetracycline (TC) by human blood albumin]. 1971 Acta Pol Pharm pmid:5004252
Chojnowski W [Comparative studies on biological activity in vitro of beta hydroxyethylpiperazin-methyltetracycline phenoxymethypenicillinate, phenoxymethylpenicillin, cloxacillin, erythromycin lactobionate, linkomycin, and tetracycline]. 1971 Acta Pol Pharm pmid:5004318
Chojnowski W et al. [Some biological properties the cyclic carbonate of erythromycin A]. 1974 Acta Pol Pharm pmid:4209091
Bojarska-Dahlig H et al. [Salts of cyclic erythromycin A carbonate with cinnamic acid derivatives]. 1975 Acta Pol Pharm pmid:1155186
Ruczaj D [Countercurrent distribution of compounds present in cultures of Streptomyces sp. 64-575]. 1969 Acta Pol Pharm pmid:5356252
Slawiński W et al. [Correlation between the structure and effect in the group of derivatives of erythromycin A]. 1969 Acta Pol Pharm pmid:5380496
Chojnowski W [Binding of some antibiotics by blood serum proteins]. 1973 Acta Pol Pharm pmid:4199236
Ruczaj D and Rambaud J [Erythromycin polymorphism]. 1976 Acta Pol Pharm pmid:1015336
Luba J and Ulikowski S [Effect of bacterial infections of fermentative medium on erythromycin biosynthesis]. 1967 Acta Pol Pharm pmid:5583960
TIBOLDI T et al. EXPERIENCE WITH SELYE'S GRANULOMA POUCH TECHNIQUE. 1964 Acta Physiol Acad Sci Hung pmid:14196571
Zhang L et al. P-glycoprotein restricted transport of nimodipine across blood-brain barrier. 2003 Acta Pharmacol. Sin. pmid:12956939
Kaltiala EH et al. Subchronic toxicity of some erythromycin compounds in rats. 1967 Acta Pharmacol Toxicol (Copenh) pmid:5630681
RASMUSSEN F Mammary excretion of benzylpenicillin, erythromycin, and penethamate hydroiodide. 1959 Acta Pharmacol Toxicol (Copenh) pmid:14436357
Berntsson P The use of non-correlated log P and (log P) 2 values in quantitative structure activity relationships. 1980 Acta Pharm. Suec. pmid:7468238
Manna PK et al. Preparation and evaluation of a new erythromycin derivative -- erythromycin taurate. 2004 Acta Pharm pmid:15610619
Ericsson HM and Sherris JC Antibiotic sensitivity testing. Report of an international collaborative study. 1971 Acta Pathol Microbiol Scand B Microbiol Immunol pmid:4325956
Dornbusch K and Dahlström A A genetic study of inducible erythromycin resistance in Staphylococcus aureus. 1973 Acta Pathol Microbiol Scand B Microbiol Immunol pmid:4275707
Thomsen M The Burns Unit in Copenhagen. 10. Antibiotic sensitivity of Staphylococcus aureus isolated from burns. 1971 Acta Pathol Microbiol Scand B Microbiol Immunol pmid:5283058
Thomsen M The Burns Unit in Copenhagen. 11. Phage types of Staphylococcus aureus and the relation to antibiotic sensitivity. 1971 Acta Pathol Microbiol Scand B Microbiol Immunol pmid:4253900
Asbjornsen G The effect of different serum concentrations of antimicrobial agents on the Lactobacillus casei folate assay. 1974 Acta Pathol Microbiol Scand B Microbiol Immunol pmid:4212402
Engbaek HC et al. Non-photochromogenic mycobacteria serotype Davis. The inhomogeneity within the serological group and the relationship to Mycobacterium avium. 1970 Acta Pathol Microbiol Scand B Microbiol Immunol pmid:4322001
Casals JB and Pedersen OG Tablet sensitivity testing: a comparison of different methods. 1972 Acta Pathol Microbiol Scand B Microbiol Immunol pmid:4345659
Gustafsson BE and Norin KE Development of germfree animal characteristics in conventional rats in antibiotics. 1977 Acta Pathol Microbiol Scand B pmid:320818
Melby K and Midtvedt T Effects of some antibacterial agents on the phagocytosis of 32P-labelled Escherichia coli by human polymorphonuclear cells. 1980 Acta Pathol Microbiol Scand B pmid:6990685
Rosendal K et al. Staphylococcus aureus strains isolated in Danish hospitals from January 1st, 1966, to December 31st, 1974. 1976 Acta Pathol Microbiol Scand B pmid:1050144
Skaug K et al. The diagnostic value of determination of IgM antibodies against Mycoplasma pneumoniae by the indirect immunofluorescent antibody test. 1976 Acta Pathol Microbiol Scand B pmid:785942
Zackrisson G and Brorson JE Antibiotic sensitivity pattern of recent clinical isolates of Streptococcus pneumoniae. 1981 Acta Pathol Microbiol Scand B pmid:6910980
LIE S PRODUCTION OF RECOMBINATINANTS IN MIXED CULTURES OF NEISSERIA MENIGITIDIS. 1965 Acta Pathol Microbiol Scand pmid:14320672
Bövre K Studies on transformation in Moraxella and organisms assumed to be related to Moraxella. 5. Streptomycin resistance transformation between serum-liquefying, nonhaemolytic moraxellae, Moraxella bovis and Moraxella nonliquefaciens. 1965 Acta Pathol Microbiol Scand pmid:5884703
ROSENDAL K and JESSEN O EPIDEMIC SPREAD OF STAPHYLOCOCCUS AUREUS PHAGE-TYPE 83A. 1964 Acta Pathol Microbiol Scand pmid:14154719
Bövre K Studies on transformation in Moraxella. and organisms assumed to be related to Moraxella 6. A distinct group of Moraxella nonliquefaciens-like organisms (the "19116/51" group). 1965 Acta Pathol Microbiol Scand pmid:5177528
Olsen H An in vitro study of the antibiotic sensitivity of Flavobacterium meningosepticum. 1967 Acta Pathol Microbiol Scand pmid:5183810
THOMSEN VF THE RELATION BETWEEN INOCULUM AND ZONE SIZE IN SENSITIVITY TESTS BY THE AGAR DIFFUSION METHOD: WITH A SPECIAL VIEW TO THE IMPORTANCE OF PREDIFFUSION. 1964 Acta Pathol Microbiol Scand pmid:14162807
Olsen H The sensitivity of Flavobacterium meningosepticum to antibiotics at different temperatures. An in vitro study. 1967 Acta Pathol Microbiol Scand pmid:5584517
Bülow P A new epidemic phage type of Staphylococcus aureus. I. The experimental typing phage 6557'. 1968 Acta Pathol Microbiol Scand pmid:4231992
Bülow P A new epidemic phage type of Staphylococcus aureus. 2. Characteristics of staphylococci lysed by phage 6557'. 1968 Acta Pathol Microbiol Scand pmid:4231993
Bülow P A new epidemic phage type of Staphylococcus aureus. 3. Occurrence and spread of "type 6557", with special reference to the consumption of some antibiotics. 1968 Acta Pathol Microbiol Scand pmid:4244485
ERIKSEN KR and ERICHSEN I RESISTANCE TO METHICILLIN, ISOXAZOLYL PENICILLINS, AND CEPHALOTHIN IN STAPHYLOCOCCUS AUREUS. 1964 Acta Pathol Microbiol Scand pmid:14235234
LUND E Erythromycin; a new antibiotic. 1953 Acta Pathol Microbiol Scand pmid:13138191
Christensen JJ et al. Chlamydia trachomatis: in vitro susceptibility to antibiotics singly and in combination. 1986 Acta Pathol Microbiol Immunol Scand B pmid:3788573
Jansen JE and Bremmelgaard A Susceptibility testing of 7 antibiotics against anaerobic bacteria: comparison of 2 different media and carbon dioxide concentrations. 1987 Acta Pathol Microbiol Immunol Scand B pmid:3105247
Andreasen JJ et al. Influence of carbon-dioxide tension and medium buffer concentration on medium pH and MIC values of erythromycin for Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923 in a micro-aerobic atmosphere. 1987 Acta Pathol Microbiol Immunol Scand B pmid:3118638
Frimodt-Møller N and Thomsen VF The pneumococcus and the mouse-protection test: correlation of in vitro and in vivo activity for beta-lactam antibiotics, vancomycin, erythromycin and gentamicin. 1987 Acta Pathol Microbiol Immunol Scand B pmid:3630711
Dibb WL et al. Effects of carbon dioxide upon the in vitro activity of erythromycin. 1986 Acta Pathol Microbiol Immunol Scand B pmid:3090858
Burova LA et al. The genetic control of virulence in group A streptococci. II. Trigger effect by plasmids on anti-phagocytic activity, opacity factor and IgG and IgA Fc-receptors. 1983 Acta Pathol Microbiol Immunol Scand B pmid:6346793
Ravdonikas LE et al. The genetic control of virulence in group A streptococci. III. Plasmid-induced "switch-off"--effect on some pathogenic properties. 1984 Acta Pathol Microbiol Immunol Scand B pmid:6369874
Digranes A et al. Coumermycin: in vitro activity against 251 clinical isolates of bacteria compared with the activities of eight other antibacterial agents. 1986 Acta Pathol Microbiol Immunol Scand B pmid:3728027
Jónsson B et al. Ureaplasma urealyticum, erythromycin and respiratory morbidity in high-risk preterm neonates. 1998 Acta Paediatr. pmid:9825977
Bhattacharya MK et al. Azithromycin in the treatment of cholera in children. 2003 Acta Paediatr. pmid:12856976